Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis)
Journal of Biological Chemistry · 2023-09 · 299 (9) · 105141
DOI: 10.1016/j.jbc.2023.105141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-09. Verfasst von Bhesh Raj Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Cell Death, DNA-Binding Proteins, Inflammasomes, Inflammation. Die Arbeit wurde bisher 138-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
The innate immune system provides the first line of defense against pathogens and cellular insults and is activated by pattern recognition receptors sensing pathogen- or damage-associated molecular patterns. This activation can result in inflammation via cytokine release as well as the induction of lytic regulated cell death (RCD). Innate immune signaling can also induce the expression of interferon regulatory factor 1 (IRF1), an important molecule in regulating downstream inflammation and cell death. While IRF1 has been shown to modulate some RCD pathways, a comprehensive evaluation of its role in inflammatory cell death pathways is lacking. Here, we examined the role of IRF1 in cell death during inflammasome and PANoptosome activation using live cell imaging, Western blotting, and ELISA in primary murine macrophages. IRF1 contributed to the induction of ZBP1- (Z-DNA binding protein 1), AIM2- (absent in melanoma-2), RIPK1- (receptor interacting protein kinase 1), and NLRP12 (NOD-like receptor family, pyrin domain-containing 12)-PANoptosome activation and PANoptosis. Furthermore, IRF1 regulated the cell death under conditions where inflammasomes, along with caspase-8 and RIPK3, act as integral components of PANoptosomes to drive PANoptosis. However, it was dispensable for other inflammasomes that form independent of the PANoptosome to drive pyroptosis. Overall, these findings define IRF1 as an upstream regulator of PANoptosis and suggest that modulating the activation of molecules in the IRF1 pathway could be used as a strategy to treat inflammatory and infectious diseases associated with aberrant inflammatory cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: Thirumala-Devi.Kanneganti@StJude.org.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIAMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- American Lebanese Syrian Associated Charities
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Cancer Institute
Zitieren
APA
Sharma, B. R., Karki, R., Rajesh, Y., & Kanneganti, T. D. (2023). Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). Journal of Biological Chemistry, 299(9), 105141. https://doi.org/10.1016/j.jbc.2023.105141
Vancouver
Sharma BR, Karki R, Rajesh Y, Kanneganti TD. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). Journal of Biological Chemistry. 2023;299(9):105141. doi:10.1016/j.jbc.2023.105141
BibTeX
@article{Sharma2023,
author = {Sharma, Bhesh Raj and Karki, Rajendra and Rajesh, Yetirajam and Kanneganti, Thirumala-Devi},
title = {Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis)},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {9},
pages = {105141},
doi = {10.1016/j.jbc.2023.105141}
}
EUVIMED